ARCHIVES

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

This article is from The Cancer Letter archive.

Vol. 25 No. 13 | April 2, 1999

Download PDF Visit The Full Archive

Related Articles

In Brief: Fox Chase Joins Temple Health System, Expands Outpatient and Surgical Services

July 6, 2012

Circulating Tumor Cells Predict Treatment Resistance In Study Of Metastatic Breast Cancer

August 30, 2013

Civin Moves From Hopkins To Maryland To Direct Stem Cell Medicine Center

January 9, 2009

Prevention & Control Study Section Needed: Letter to the Editor

June 11, 1993

NCI, CCSG Collaborating On Electromagnetic Field Exposure Study

April 6, 1990

Racker Withdraws Some Claims Made In Science Article, Says Data Are “No Question A Mess”

September 11, 1981